Literature DB >> 2900841

Simple assay procedure for tyrosine hydroxylase activity by high-performance liquid chromatography employing coulometric detection with minimal sample preparation.

M Naoi1, T Takahashi, T Nagatsu.   

Abstract

A simple assay procedure for tyrosine hydroxylase activity in crude tissue samples was devised that requires minimal sample preparation and use of high-performance liquid chromatography with coulometric electrochemical detection. After incubation of enzyme samples, such as human brain homogenates or rat pheochromocytoma PC12h cells, with L-tyrosine and a tetrahydropterin cofactor, in the presence or absence of p-bromobenzyloxyamine, an inhibitor of aromatic L-amino acid decarboxylase, the reaction was terminated by addition of an equal volume of 0.1 M perchloric acid. For quantitation of L-DOPA produced, the sample was centrifuged, filtered and directly applied to the chromatographic apparatus connected to a coulometric electrochemical detector. This method makes redundant a time-consuming step in the previous methods, purification and concentration of L-DOPA or dopamine using alumina. The reaction conditions for the assay of tyrosine hydroxylase activity in brain homogenates and PC12h cells were re-examined by this method. Both tyrosine hydroxylase samples required a naturally occurring cofactor, (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin [(6R)BH4], catalase and NSD-1055 for the full activity, and tyrosine hydroxylase in human brain homogenates required Fe2+ ions for its full activity. (6R)BH4 proved to be a more effective cofactor than a synthetic cofactor, (6RS)-methyl-5,6,7,8-tetrahydropterin, which is commonly used for this assay.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2900841     DOI: 10.1016/0378-4347(88)80125-7

Source DB:  PubMed          Journal:  J Chromatogr


  8 in total

1.  A novel nonneuronal catecholaminergic system: exocrine pancreas synthesizes and releases dopamine.

Authors:  E Mezey; G Eisenhofer; G Harta; S Hansson; L Gould; B Hunyady; B J Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

2.  Analytical characterization of a sensitive radioassay for tyrosine hydroxylase activity in rodent striatum.

Authors:  Haseeb Ahmad Khan
Journal:  Neurochem Res       Date:  2004-08       Impact factor: 3.996

3.  The mechanism of perturbation in monoamine metabolism by L-dopa therapy: in vivo and in vitro studies.

Authors:  W Maruyama; M Naoi; A Takahashi; H Watanabe; Y Konagaya; K Mokuno; S Hasegawa; D Nakahara
Journal:  J Neural Transm Gen Sect       Date:  1992

4.  The I2020T Leucine-rich repeat kinase 2 transgenic mouse exhibits impaired locomotive ability accompanied by dopaminergic neuron abnormalities.

Authors:  Tatsunori Maekawa; Sayuri Mori; Yui Sasaki; Takashi Miyajima; Sadahiro Azuma; Etsuro Ohta; Fumiya Obata
Journal:  Mol Neurodegener       Date:  2012-04-25       Impact factor: 14.195

5.  Effect of parasitic infection on dopamine biosynthesis in dopaminergic cells.

Authors:  H L Martin; I Alsaady; G Howell; E Prandovszky; C Peers; P Robinson; G A McConkey
Journal:  Neuroscience       Date:  2015-08-20       Impact factor: 3.590

Review 6.  From the tyrosine hydroxylase hypothesis of Parkinson's disease to modern strategies: a short historical overview.

Authors:  Wolf-Dieter Rausch; Feixue Wang; Khaled Radad
Journal:  J Neural Transm (Vienna)       Date:  2022-04-23       Impact factor: 3.850

7.  Metabolic consequences and vulnerability to diet-induced obesity in male mice under chronic social stress.

Authors:  Alessandro Bartolomucci; Aderville Cabassi; Paolo Govoni; Graziano Ceresini; Cheryl Cero; Daniela Berra; Harold Dadomo; Paolo Franceschini; Giacomo Dell'Omo; Stefano Parmigiani; Paola Palanza
Journal:  PLoS One       Date:  2009-01-30       Impact factor: 3.240

8.  Glucagon-like peptide 1 receptor stimulation reverses key deficits in distinct rodent models of Parkinson's disease.

Authors:  Alexander Harkavyi; Amjad Abuirmeileh; Rebecca Lever; Ann E Kingsbury; Christopher S Biggs; Peter S Whitton
Journal:  J Neuroinflammation       Date:  2008-05-21       Impact factor: 8.322

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.